tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
DRMA
Dermata Therapeutics
RESEARCH TOOLSreports
Want to see DRMA full AI Analyst Report?

Dermata Therapeutics (DRMA) Stock News & Sentiment

150 Followers
Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4
Premium
Ratings
Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4
1d ago
DRMA
Dermata Therapeutics Announces Board Resignation and Size Reduction
Premium
Company Announcements
Dermata Therapeutics Announces Board Resignation and Size Reduction
3M ago
8K
DRMA
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
Premium
Company Announcements
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
4M ago
8K
DRMA
Dermata Therapeutics Raises Capital via December Private Placement
Premium
Company Announcements
Dermata Therapeutics Raises Capital via December Private Placement
5M ago
8K
DRMA
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
Premium
Ratings
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
6M ago
DRMA
Dermata Therapeutics Ends License Agreement with Villani
Premium
Company Announcements
Dermata Therapeutics Ends License Agreement with Villani
6M ago
8K
DRMA
Dermata Therapeutics Shifts Focus to OTC Skincare
Premium
Company Announcements
Dermata Therapeutics Shifts Focus to OTC Skincare
6M ago
8K
DRMA
More DRMA News >

DRMA News on the Web

Dermata receives notice of acceptance of Australian patent application
TipRanks News
Bullish
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
TipRanks News
Bearish
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
TipRanks News
Bullish
Dermata Therapeutics (DRMA) Launches Tome: A New Era in Home Skincare
GuruFocus News
Bullish
Dermata Therapeutics announces release of Tome Skincare
TipRanks News
Bullish
Dermata Therapeutics Announces Board Resignation and Size Reduction
TipRanks News
Neutral
ARMISTICE CAPITAL, LLC Reduces Stake in Dermata Therapeutics Inc
GuruFocus News
Bearish
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
TipRanks News
Bearish

News Score - Last 7 Days

Very Positive
DRMA
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DRMA’s Media Buzz Sentiment?
Currently, no data Available
What is DRMA’s weekly average amount of articles?
Currently, no data Available
What is DRMA’s News Sentiment?
100% of articles about DRMA were positive this week, compared to its sector average of 76%.
    Healthcare Stocks that are Trending in the News
    GOSSGossamer Bio
    RLAYRelay Therapeutics
    CGENCompugen
    PROKProKidney
    ROIVRoivant Sciences
    Showing the stocks with the most bullish news sentiment over the past week